Drugmakers Curb Swiss Reimbursement Applications over US Pricing Concerns

Drugmakers curb Swiss reimbursement applications over US pricing concerns

By Marleen Kaesebier ZURICH, Aug 13 (Reuters) - Drugmakers are holding back applications for health insurance coverage in Switzerland over concerns that lower prices there could affect their U.S. business under ​drug-pricing policies introduced by the ...

Drugmakers, health insurers battle over coupons for high-cost medicine

Patients with cancer, HIV, cystic fibrosis or conditions with high-cost medications often use coupons from drug manufacturers to help them pay for the drugs. That assistance runs out, however, and patients learn that the money was not counted toward their insurance deductible.